Around 10–15% of MM patients harbor the t(4;14)(p16;q32) translocation that results in overexpression of the receptor tyrosine kinase FGFR3 and the histone methyltransferase MMSET [1,2]. This evidence concerns the gene NSD2 and Miyoshi myopathy.